Meeder Advisory Services’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $13.4M | Buy |
17,227
+279
| +2% | +$217K | 0.7% | 27 |
|
2025
Q1 | $14M | Buy |
16,948
+646
| +4% | +$534K | 0.84% | 23 |
|
2024
Q4 | $12.6M | Buy |
16,302
+541
| +3% | +$418K | 0.79% | 24 |
|
2024
Q3 | $14M | Buy |
15,761
+438
| +3% | +$388K | 0.9% | 22 |
|
2024
Q2 | $13.9M | Buy |
15,323
+4,471
| +41% | +$4.05M | 0.98% | 19 |
|
2024
Q1 | $8.44M | Buy |
10,852
+300
| +3% | +$233K | 0.86% | 21 |
|
2023
Q4 | $6.15M | Sell |
10,552
-72
| -0.7% | -$42K | 0.7% | 24 |
|
2023
Q3 | $5.71M | Sell |
10,624
-603
| -5% | -$324K | 0.72% | 25 |
|
2023
Q2 | $5.27M | Buy |
11,227
+575
| +5% | +$270K | 0.57% | 29 |
|
2023
Q1 | $3.66M | Sell |
10,652
-549
| -5% | -$189K | 0.42% | 39 |
|
2022
Q4 | $4.1M | Buy |
+11,201
| New | +$4.1M | 0.52% | 32 |
|